JP2024527044A5 - - Google Patents
Info
- Publication number
- JP2024527044A5 JP2024527044A5 JP2024504951A JP2024504951A JP2024527044A5 JP 2024527044 A5 JP2024527044 A5 JP 2024527044A5 JP 2024504951 A JP2024504951 A JP 2024504951A JP 2024504951 A JP2024504951 A JP 2024504951A JP 2024527044 A5 JP2024527044 A5 JP 2024527044A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- mmol
- compound
- oxa
- azabicyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110860428.3 | 2021-07-27 | ||
| CN202110860428 | 2021-07-27 | ||
| CN202210779302 | 2022-07-01 | ||
| CN202210779302.8 | 2022-07-01 | ||
| PCT/CN2022/107932 WO2023005928A1 (zh) | 2021-07-27 | 2022-07-26 | 8-氧-3-氮杂二环[3.2.1]辛烷类化合物或其盐及其制备方法和用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527044A JP2024527044A (ja) | 2024-07-19 |
| JP2024527044A5 true JP2024527044A5 (https=) | 2025-07-30 |
Family
ID=85060847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024504951A Pending JP2024527044A (ja) | 2021-07-27 | 2022-07-26 | ８－オキソ－３－アザビシクロ［３．２．１］オクタン系化合物及びその塩、並びにその調製方法及び使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240294550A1 (https=) |
| EP (1) | EP4378943A4 (https=) |
| JP (1) | JP2024527044A (https=) |
| KR (1) | KR20240041354A (https=) |
| CN (2) | CN118043325A (https=) |
| AU (1) | AU2022316931A1 (https=) |
| CA (1) | CA3227713A1 (https=) |
| IL (1) | IL310412A (https=) |
| TW (1) | TW202321256A (https=) |
| WO (1) | WO2023005928A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202602891A (zh) * | 2024-03-28 | 2026-01-16 | 大陸商勵締（杭州）醫藥科技有限公司 | 具有mTOR抑制活性的有機化合物及其用途 |
| TW202545519A (zh) * | 2024-05-15 | 2025-12-01 | 俄羅斯聯邦商拜奧卡德聯合股份公司 | 共濟失調毛細血管擴張症和Ｒａｄ３相關激酶抑制劑 |
| WO2026037494A1 (en) * | 2024-08-14 | 2026-02-19 | Eracal Therapeutics Ltd. | New compounds and their uses |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI656121B (zh) * | 2014-08-04 | 2019-04-11 | 德商拜耳製藥公司 | ２－（嗎啉－４－基）－１，７－萘啶 |
| WO2017202748A1 (en) | 2016-05-24 | 2017-11-30 | Merck Patent Gmbh | Tricyclic heterocylic derivatives |
| CN112654396B (zh) * | 2018-09-07 | 2025-07-01 | 默克专利股份公司 | 5-吗啉-4-基-吡唑并[4,3-b]吡啶衍生物 |
| AU2019373416A1 (en) * | 2018-10-30 | 2021-06-10 | Repare Therapeutics Inc. | Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as ATR kinase inhibitors |
| CN111848605B (zh) | 2019-04-30 | 2023-05-02 | 四川科伦博泰生物医药股份有限公司 | 一种取代吡啶并[3,4-b]吡嗪-2(1H)-酮化合物、其制备方法和用途 |
| CN112142744A (zh) * | 2019-06-28 | 2020-12-29 | 上海瑛派药业有限公司 | 取代的稠合杂芳双环化合物作为激酶抑制剂及其应用 |
| KR20220035925A (ko) * | 2019-07-22 | 2022-03-22 | 리페어 세라퓨틱스 인크. | Atr 키나제 억제제로서의 치환된 2-모르폴리노피리딘 유도체 |
| TW202220993A (zh) * | 2020-08-07 | 2022-06-01 | 香港商德琪研發有限公司 | Atr抑制劑及其用途 |
-
2022
- 2022-07-26 TW TW111127974A patent/TW202321256A/zh unknown
- 2022-07-26 KR KR1020247006386A patent/KR20240041354A/ko active Pending
- 2022-07-26 US US18/292,437 patent/US20240294550A1/en active Pending
- 2022-07-26 WO PCT/CN2022/107932 patent/WO2023005928A1/zh not_active Ceased
- 2022-07-26 IL IL310412A patent/IL310412A/en unknown
- 2022-07-26 EP EP22848533.0A patent/EP4378943A4/en active Pending
- 2022-07-26 AU AU2022316931A patent/AU2022316931A1/en active Pending
- 2022-07-26 JP JP2024504951A patent/JP2024527044A/ja active Pending
- 2022-07-26 CN CN202280052257.4A patent/CN118043325A/zh active Pending
- 2022-07-26 CN CN202210884665.8A patent/CN115677730B/zh active Active
- 2022-07-26 CA CA3227713A patent/CA3227713A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10233186B2 (en) | Inhibitors of activin receptor-like kinase | |
| JP2025532125A (ja) | 新規なテトラヘテロサイクル化合物 | |
| US20240270753A1 (en) | Heterocyclic compound for inhibiting shp2 activity, preparation method therefor and use thereof | |
| CN117917416A (zh) | Kras g12d降解剂及其制备方法和应用 | |
| WO2020211798A1 (zh) | 含二并环类衍生物抑制剂、其制备方法和应用 | |
| WO2020253862A1 (zh) | 含氮芳基磷氧化物类衍生物、其制备方法和应用 | |
| JP2025523624A (ja) | がんの治療のための方法 | |
| CN106687446B (zh) | 作为t790m/wt-egfr的选择性和不可逆的激酶抑制剂的5-氨基-4-氨甲酰基-吡唑化合物及其用途 | |
| JP2024527044A5 (https=) | ||
| JP2020511520A (ja) | ピラゾロ［３，４−ｄ］ピリミジン−３−オンの大環状誘導体、その医薬組成物及び応用 | |
| JP7706585B2 (ja) | 毛細血管拡張性運動失調症変異（ＡＴＭ）キナーゼの選択的調節物質としての１－イソプロピル－３－メチル－８－（ピリジン－３－イル）－１，３－ジヒドロ－２Ｈ－イミダゾ［４，５－ｃ］シンノリン－２－オンおよびその使用 | |
| TW202237597A (zh) | 新型egfr降解劑 | |
| JP2023518609A (ja) | 新規アミノピリミジン系ｅｇｆｒ阻害剤 | |
| WO2017071516A1 (zh) | 一种蛋白激酶抑制剂及其制备方法和医药用途 | |
| JP2024527044A (ja) | ８－オキソ－３－アザビシクロ［３．２．１］オクタン系化合物及びその塩、並びにその調製方法及び使用 | |
| AU2022345314B2 (en) | Azaindazole macrocyclic compound and use thereof | |
| EP4077297A1 (en) | Cd206 modulators their use and methods for preparation | |
| US12528799B2 (en) | Heteroaryl derivative compounds, and uses thereof | |
| CN116375712A (zh) | 双吗啉取代的杂环化合物及其医药用途 | |
| JP7833477B2 (ja) | 血管拡張性失調症変異（ａｔｍ）キナーゼの選択的モジュレーターおよびその使用 | |
| TWI894448B (zh) | Ctla-4小分子降解劑及其應用 | |
| EA050883B1 (ru) | 8-окса-3-азабицикло[3.2.1]октановые соединения или их соли, способ их получения и применение | |
| TWI918767B (zh) | 含二并環類衍生物抑制劑自由鹼的晶型及其製備方法和應用 | |
| HK40082693A (en) | 8-oxo-3-azabicyclo[3.2.1]octane compounds or salts thereof, and preparation method and use thereof | |
| US20250092052A1 (en) | Heteroaryl derivative compounds, and uses thereof |